LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | PF477736 | 3.33 | uM | LJP5 | 72 | hr | 658 | 566 | 3846 | 0.1473 | -0.0288 |
Hs 578T | PF562271 | 3.33 | uM | LJP6 | 72 | hr | 658 | 1573 | 3846 | 0.4092 | 0.2872 |
Hs 578T | PHA-665752 | 3.33 | uM | LJP5 | 72 | hr | 658 | 3707 | 3846 | 0.9638 | 0.9564 |
Hs 578T | PHA-793887 | 3.33 | uM | LJP6 | 72 | hr | 658 | 534 | 3846 | 0.1388 | -0.0390 |
Hs 578T | PI103 | 3.33 | uM | LJP6 | 72 | hr | 658 | 1230 | 3846 | 0.3198 | 0.1794 |
Hs 578T | PLX-4720 | 3.33 | uM | LJP5 | 72 | hr | 658 | 3690 | 3846 | 0.9596 | 0.9512 |
MCF7 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1209 | 3086 | 4093 | 0.7541 | 0.6510 |
Hs 578T | QL-X-138 | 3.33 | uM | LJP6 | 72 | hr | 658 | 1318 | 3846 | 0.3428 | 0.2071 |
Hs 578T | QL-XII-47 | 3.33 | uM | LJP6 | 72 | hr | 658 | 640 | 3846 | 0.1666 | -0.0055 |
Hs 578T | Radicicol | 3.33 | uM | LJP5 | 72 | hr | 658 | 687 | 3846 | 0.1788 | 0.0092 |
Hs 578T | Radicicol | 3.33 | uM | LJP6 | 72 | hr | 658 | 686 | 3846 | 0.1785 | 0.0089 |
Hs 578T | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 658 | 3388 | 3846 | 0.8811 | 0.8565 |
Hs 578T | Ruxolitinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 3559 | 3846 | 0.9254 | 0.9099 |
Hs 578T | XL147 | 3.33 | uM | LJP5 | 72 | hr | 658 | 3861 | 3846 | 1.0039 | 1.0047 |
Hs 578T | Saracatinib | 3.33 | uM | LJP6 | 72 | hr | 658 | 2520 | 3846 | 0.6554 | 0.5842 |
Hs 578T | Selumetinib | 3.33 | uM | LJP6 | 72 | hr | 658 | 1534 | 3846 | 0.3990 | 0.2749 |
Hs 578T | Sirolimus | 3.33 | uM | LJP6 | 72 | hr | 658 | 2419 | 3846 | 0.6291 | 0.5526 |
Hs 578T | Sorafenib | 3.33 | uM | LJP6 | 72 | hr | 658 | 3885 | 3846 | 1.0103 | 1.0124 |
Hs 578T | SU11274 | 3.33 | uM | LJP5 | 72 | hr | 658 | 3226 | 3846 | 0.8389 | 0.8056 |
Hs 578T | Fedratinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 1270 | 3846 | 0.3302 | 0.1919 |
Hs 578T | TGX221 | 3.33 | uM | LJP5 | 72 | hr | 658 | 3510 | 3846 | 0.9126 | 0.8946 |
Hs 578T | Torin1 | 3.33 | uM | LJP6 | 72 | hr | 658 | 748 | 3846 | 0.1947 | 0.0284 |
Hs 578T | Torin2 | 3.33 | uM | LJP5 | 72 | hr | 658 | 533 | 3846 | 0.1386 | -0.0393 |
Hs 578T | Tozasertib | 3.33 | uM | LJP5 | 72 | hr | 658 | 791 | 3846 | 0.2058 | 0.0418 |
Hs 578T | Trametinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 905 | 3846 | 0.2353 | 0.0774 |